Titan Receives Notice Of Allowance For Probuphine(R) Patent Application In The Treatment Of Opiate Addiction (Medical News Today)

More info…
Titan Pharmaceuticals, Inc (Pink Sheets:TTNP) announced that the United States Patent and Trademark Office (USPTO) has issued a Notice of Allowance for Titan’s United States patent application directed to the use of Probuphine for the treatment of opiate addiction. The patent application is U.S. Application No. 10/453,377 filed June 2, 2003 titled “Implantable polymeric device for sustained …

opiate detox